Table 6. Clinical Outcomes between aspirin non-response patients and aspirin sensitive patients who did not receive the modified antiplatelet therapy.
| Variable | aspirin sensitive patients (n = 539) | aspirin non-responders (n = 69) | P value |
|---|---|---|---|
| Ischemic events (n, %) | 115 (21.3) | 23 (33.3) | 0.03 |
| Ischemic stroke (n, %) | 74 (13.7) | 17 (24.6) | 0.02 |
| Transient ischemic attack (n, %) | 26 (4.8) | 3 (4.3) | 0.88 |
| Myocardial infarction (n, %) | 15 (3.3) | 3 (4.3) | 0.43 |
| Any bleeding event | 54 (10.0) | 6 (8.7) | 0.74 |
| GUSTO minor (n, %) | 27 (5.0) | 4 (5.8) | 0.81 |
| GUSTO moderate (n, %) | 20 (3.7) | 1 (1.4) | 0.36 |
| GUSTO severe (n, %) Gastrointestinal bleeding (n, %) Intracerebral hemorrhage (n, %) |
7 (1.3) 38 (7.1) 6 (1.1) |
1 (1.4) 3 (4.3) 1 (1.4) |
0.98 0.45 0.86 |
| Death (n, %) | 16 (3.0) | 3 (4.3) | 0.56 |
GUSTO, Global Use of Strategies to Open Occluded Coronary Arteries.